Navigation Links
Experiments reveal unexpected activity of fuel cell catalysts
Date:12/13/2007

UPTON, NY -- Researchers at the U.S. Department of Energys Brookhaven National Laboratory have unveiled important details about a class of catalysts that could help improve the performance of fuel cells. With the goal of producing clean hydrogen for fuel cell reactions in mind, the researchers determined why two next-generation catalysts including gold, cerium, titanium, and oxygen nanomaterials exhibit very high activity. Their results will be published online in the December 14, 2007, edition of the journal Science.

Fuel cells combine hydrogen and oxygen without combustion to produce direct electrical power and water. They are attractive as a source of power for transportation applications because of their high energy efficiency, the potential for using a variety of fuel sources, and their zero emissions. However, a major problem facing this technology is that the hydrogen-rich materials feeding the reaction often contain carbon monoxide (CO), which is formed during hydrogen production. Within a fuel cell, CO poisons the expensive platinum-based catalysts that convert hydrogen into electricity, deteriorating their efficiency over time and requiring their replacement.

Fuel cell reactions are very demanding processes that require very pure hydrogen, said Brookhaven chemist Jose Rodriguez. You need to find some way to eliminate the impurities, and thats where the water-gas shift reaction comes into play.

The water-gas shift (WGS) reaction combines CO with water to produce additional hydrogen gas and carbon dioxide. With the assistance of proper catalysts, this process can convert nearly 100 percent of the CO into carbon dioxide. Rodriguezs group, which includes researchers from Brookhavens chemistry department, the Center for Functional Nanomaterials (CFN), and the Central University of Venezuela, studied two next-generation WGS nanoscale catalysts: gold-cerium oxide and gold-titanium oxide.

These nanomaterials have recently
'/>"/>

Contact: Karen McNulty Walsh
kmcnulty@bnl.gov
631-344-8350
DOE/Brookhaven National Laboratory
Source:Eurekalert

Page: 1 2

Related biology technology :

1. New Survey Reveals Many Adults With High Cholesterol Fail to Take Necessary Steps to Improve Their Condition
2. Actelion Announces Multiple Presentations on Tracleer(R) and the REVEAL Registry at CHEST 2007
3. New Data Reveal Ethnicity May Play Role in Weight Loss Decisions
4. New paper reveals nanoscale details of photolithography process
5. Stem Cell Agency Finally Reveals Institutions Involved in Conflict Problem
6. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
7. ANX-514 Reduces Hypersensitivity Reactions Without Impacting Pharmacokinetics or Antitumor Activity in Preclinical Tests
8. Celator(R) Pharmaceuticals Study Shows CPX-571 Maintains Synergistic Ratio of Irinotecan and Cisplatin to Improve Anti-tumor Activity
9. Brostallicin Trial Data Demonstrates Encouraging Anti-tumor Activity in Patients With Chemotherapy-Resistant Cancers
10. Using catalysts to stamp nanopatterns without ink

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... , SAN MATEO, Calif., Nov. 24 /PRNewswire... biopharmaceutical company focused on developing a..., announced today that Anthony DiTonno, President ...nt at the 21st Annual Piper Jaffray Health Care Co... York Palace Hotel in New York, New York. ,, M...
(Date:11/24/2009)... The FBI recently approved th...tories participating in or generating DNA records ... Madison, WI USA (PRWEB) -- The FBI rec...ystem for use by laboratories participating in, o...ex System (NDIS). NDIS currently contains more tha...
(Date:11/24/2009)... , DUBLIN, November 24 /PRNewswire-First...e global specialty biopharmaceutical company, toda...opean Medicines Agency for,velaglucerase alfa, the...nt,for the treatment of Type 1 Gaucher disease. Th...erase alfa that has been submitted, with previous,...
(Date:11/24/2009)... , BOZEN, Italy, November 24 /PRNewswi... formed a new Canadian joint venture with a group ...o-based company will operate under the,name Health...nd support,Health Robotics, i.v. Room of the Futur...t offerings i.v.STATION(TM), i.v.SOFT(TM), and OMM...
Breaking Biology Technology:NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 4Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 3
...e nation,s top-10 GPOs(1), IRVINE, Calif., Jan. 2...ead-Through Motion and Low Perfusion pulse,oximetr...lier agreement,with HealthTrust Purchasing Group (...ies, including acute care hospitals, ambulatory su...practices, with an annual,purchasing volume of mor...
...surement of Women,s Ovarian ...ductive Specialists (GRS),today announced it will ...the Repromedix Plan Ahead(TM) test, an innovative ...s egg supply by combining multiple factors,includi...Inhibin B, and,FSH. The window of opportunity for ...
...t renin inhibitor with the diuretic hydroc...ow combination of Tekturna and HCTZ resulted in si...ompared to either drug alone - Many treated patie... medicines - single-tablet combinations simplify ...f pills patients take, EAST HANOVER, N.J., Jan. 2...
Other Biology Technology:Masimo Awarded Multi-Year Pulse Oximetry Agreement with HealthTrust Purchasing Group 2Masimo Awarded Multi-Year Pulse Oximetry Agreement with HealthTrust Purchasing Group 3Masimo Awarded Multi-Year Pulse Oximetry Agreement with HealthTrust Purchasing Group 4Georgia Reproductive Specialists is First in Southeast to Offer Pioneering Test of Women's Biological Clock 2Georgia Reproductive Specialists is First in Southeast to Offer Pioneering Test of Women's Biological Clock 3Video and Photo: Tekturna HCT(R), a Single-tablet Combination of Tekturna(R)* and a Diuretic, Receives US Approval for Treatment of High Blood Pressure 2Video and Photo: Tekturna HCT(R), a Single-tablet Combination of Tekturna(R)* and a Diuretic, Receives US Approval for Treatment of High Blood Pressure 3Video and Photo: Tekturna HCT(R), a Single-tablet Combination of Tekturna(R)* and a Diuretic, Receives US Approval for Treatment of High Blood Pressure 4Video and Photo: Tekturna HCT(R), a Single-tablet Combination of Tekturna(R)* and a Diuretic, Receives US Approval for Treatment of High Blood Pressure 5
(Date:11/25/2009)...eptember 11, firefighters, police officers and amb... the World Trade Center complex. They battled to s...ed for survivors, tackled fires and evacuated as m...d an estimated 17,000 people. And making their job...ns: frightened workers and their relatives jammed ...
(Date:11/25/2009)... JOLLA, CAWhen you eat may be just as vital to you... Salk Institute for Biological Studies. Their expe... waning of thousands of genes in the liverthe body...food intake and not by the body,s circadian clock ...me determines the activity of a large number of ge...
(Date:11/24/2009)...ts that keep weakened and flabby arteries from col...months, those stents are no longer needed -- once ...sary. Previously, doctors had no choice but to lea...l Aviv University,s Department of Biomedical Engin...atform that carries drugs where they,re needed, th...
Breaking Biology News(10 mins):Magic box for mission impossible 2Magic box for mission impossible 3Feeding the clock 2Feeding the clock 3A coating for life 2MAP Pharmaceuticals Reports Second Quarter of 2009 Financial Results 53457 1MAP Pharmaceuticals Reports Second Quarter of 2009 Financial Results 53457 2MAP Pharmaceuticals Reports Second Quarter of 2009 Financial Results 53457 3MAP Pharmaceuticals Reports Second Quarter of 2009 Financial Results 53457 4MAP Pharmaceuticals Reports Second Quarter of 2009 Financial Results 53457 5MAP Pharmaceuticals Reports Second Quarter of 2009 Financial Results 53457 6MAP Pharmaceuticals Reports Second Quarter of 2009 Financial Results 53457 7Locum Leaders Taps Hospitalist as Chief Medical Officer 3B Strengthens Leadership in Hospital Medicine Recruitment and Job Placement 53452 1Locum Leaders Taps Hospitalist as Chief Medical Officer 3B Strengthens Leadership in Hospital Medicine Recruitment and Job Placement 53452 2Access Pharmaceuticals Provides Update on ProLindac Clinical Development Program 4811 1Access Pharmaceuticals Provides Update on ProLindac Clinical Development Program 4811 2Access Pharmaceuticals Provides Update on ProLindac Clinical Development Program 4811 3Access Pharmaceuticals Provides Update on ProLindac Clinical Development Program 4811 4
...MIT researchers have developed a technique to enco... a step that could help realize the therapeutic po...n many tissues in the body, are precursor cells fo...nd in the bone marrow develop into blood cells, bo...stem cells develop into brain tissue. , Those s...
...Researchers at Mount Sinai School of Medicine have...apture the movement of the microdomains of leukocy...ted areas on the surface of the cells in which rec...ell activation. Using digital multi-channel videom...od cell subsets and their forming microdomains in ...
...DNA testing is transforming health care and medici...of an individual,s genetic makeup. Any patient wan... genome, would drop their jaw at the sight of the ... charged for every human or mammalian-sized genome...ional Human Genome Research Institute (NHGRI), sci...
Other Biology News:MIT bioengineer advances survival, promise of adult stem cells 2MIT bioengineer advances survival, promise of adult stem cells 3New imaging technique tracks traffic patterns of white blood cells 2Faster, low cost sequencing technologies needed to drive era of personalized medicine 2Faster, low cost sequencing technologies needed to drive era of personalized medicine 3
Tramadol ELISA Kit, Single from Bio-Quant Inc.
...h Registered OLAW Assured AAALAC Accredited All Pr...ed Technicians Documentation GLP Process for All... CRP is your one stop shopping point for all your ...oject consultation, free peptide sequence recommen...
Dengue Virus IgM ELISA Kit, Single from Bio-Quant Inc.
THC ELISA Kit, Single from Bio-Quant Inc.
Biology Products: